Fresenius SE & Co. KGaA
Home
|
Contacts
|
Imprint
|
Sitemap
|
Glossary
|
RSS
|
German
Who we are
The Health Care Group
Products and Services
Facts and Figures
Locations Worldwide
Management Board
Supervisory Board
Corporate Governance
Business Development / M&A
Environment
History
Frequently Asked Questions
Contacts
Investor Relations
Fresenius Share/ADR
Credit Relations
News
Publications
Presentations
Directors' Dealings
Outlook, Facts and Figures
Annual General Meeting
Financial Calendar and Conferences
Information & Order Service
Frequently Asked Questions
Contacts
Stock Dictionary
Press
Press Releases
Photo Service
Audio / Video Service
TV Service
Calendar
Facts and Figures
Contacts
Health Care
Fresenius Medical Care
Dialysis at a Clinic or at Home
Hemodialysis
Peritoneal Dialysis
Supplemental Drugs
Other Extracorporeal Systems
Fresenius Kabi
Infusion Therapy
Clinical Nutrition
Home Care
Fresenius Helios
Care Structure
Medical Quality
Knowledge Management
HELIOS Highlights
Fresenius Vamed
Fresenius Biotech
Transplantation
Cancer Therapy
All Segments
Calendar
Links
Contacts
Career
SEARCH
Press Releases
All
Business & Finance
Quarterly Results
Medicine & Research
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Order Service
Photo Service
Audio / Video Service
TV Service
Calendar
Facts and Figures
Contacts
Share Price
Next Event
12.06.2012
Capital Market Day Fresenius Kabi
>>>
Further events
>>>
Medicine & Research - 2002
29.10.2002
Fresenius announces results of first nine months of 2002
Text as PDF-file
05.03.2002
Fresenius Medical Care AG reports fourth quarter and full year 2001 Results; 2001 Earnings grew 15% to $ 245 million; fourth quarter Free-Cash Flow and full year operating Cash Flow at record levels
07.02.2002
Marie Curie Industry Host Award
Home
>
Press
>
Press Releases
>
Medicine & Research
>
2002
